Alterity Therapeutics (Alterity Therapeutics) Price-to-Tangible-Book : (As of Apr. 25, 2024)

View and export this data going back to 2002. Start your Free Trial

What is Alterity Therapeutics Price-to-Tangible-Book?

As of today (2024-04-25), Alterity Therapeutics's share price is $2.33. Alterity Therapeutics's Tangible Book per Share of Sep. 2023 for the quarter that ended in Sep. 2023 was $0.00. Hence, Alterity Therapeutics's Price to Tangible Book Ratio of today is .

The historical rank and industry rank for Alterity Therapeutics's Price-to-Tangible-Book or its related term are showing as below:

ATHE' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.6 Med: 1.6 Max: 16.04
Current: 0.66

During the past 13 years, Alterity Therapeutics's highest Price to Tangible Book Ratio was 16.04. The lowest was 0.60. And the median was 1.60.

ATHE's Price-to-Tangible-Book is ranked better than
91.64% of 1220 companies
in the Biotechnology industry
Industry Median: 2.67 vs ATHE: 0.66

A closely related ratio is called PB Ratio. As of today, Alterity Therapeutics's share price is $2.33. Alterity Therapeutics's Book Value per Sharefor the quarter that ended in Sep. 2023 was $0.00. Hence, Alterity Therapeutics's P/B Ratio of today is .

Alterity Therapeutics Price-to-Tangible-Book Historical Data

The historical data trend for Alterity Therapeutics's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alterity Therapeutics Price-to-Tangible-Book Chart

Alterity Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Price-to-Tangible-Book

Get a 7-Day Free Trial

1.63

4.17

1.94

0.98

0.74

Alterity Therapeutics Quarterly Data
	Dec17	Jun18	Dec18	Jun19	Sep19	Dec19	Jun20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															0.74	-	0.74	-	-

Competitive Comparison of Alterity Therapeutics's Price-to-Tangible-Book

For the Biotechnology subindustry, Alterity Therapeutics's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alterity Therapeutics's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Alterity Therapeutics's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Alterity Therapeutics's Price-to-Tangible-Book falls into.

Alterity Therapeutics Price-to-Tangible-Book Calculation

Alterity Therapeutics's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Sep. 2023 )
	=	2.33	/	0
	=

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Alterity Therapeutics Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Alterity Therapeutics's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Alterity Therapeutics (Alterity Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alterity Therapeutics Ltd (NAS:ATHE) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

PBN:Germany ATH:Australia

Address

350 Collins Street, Level 14, Melbourne, VIC, AUS, 3000

Website

https://www.alteritytherapeutics.com

Alterity Therapeutics Ltd is active in the healthcare domain. The company is engaged in research collaborations for the treatment of Parkinsonian movement disorders, Alzheimer's disease, Huntington disease, and other neurodegenerative disorders. The company's lead drug candidate-PBT2 is being developed for the treatment of Alzheimer's and Huntington's diseases. It has also advanced a drug candidate for Parkinson's disease and other movement disorders (ATH434). The Group operated in one segment, being researching and developing Parkinsonian and other neurodegenerative disorders.